Colorectal Cancer Coverage from Every Angle
Advertisement
Advertisement

Van K. Morris, MD, on Circulating Tumor DNA: A Biomarker in Early-Stage Colon Cancer?

Posted: Tuesday, February 25, 2020

Van K. Morris, MD, of The University of Texas MD Anderson Cancer Center, discusses how circulating tumor DNA may help determine what kind and/or how much adjuvant chemotherapy to recommend for patients with stage II colon cancer, or whether select patients might be able to forgo adjuvant treatment.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.
Advertisement
Advertisement